Colgate-Palmolive (WKN: 850667) eine der konstantesten Wachstumssaktien (Seite 8)
eröffnet am 02.01.08 18:15:47 von
neuester Beitrag 16.11.23 20:49:47 von
neuester Beitrag 16.11.23 20:49:47 von
Beiträge: 251
ID: 1.136.871
ID: 1.136.871
Aufrufe heute: 1
Gesamt: 51.519
Gesamt: 51.519
Aktive User: 0
ISIN: US1941621039 · WKN: 850667
85,23
EUR
0,00 %
0,00 EUR
Letzter Kurs 12:59:37 Lang & Schwarz
Neuigkeiten
| Titel |
|---|
26.05.24 · Aktienwelt360 |
22.05.24 · Business Wire (engl.)  |
29.04.24 · Business Wire (engl.) |
26.04.24 · dpa-AFX |
26.04.24 · Business Wire (engl.) |
Werte aus der Branche Konsum
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 39,60 | +31,13 | |
| 42.865,50 | +19,78 | |
| 10,750 | +10,03 | |
| 0,8487 | +10,01 | |
| 14,870 | +9,99 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 169,90 | -7,66 | |
| 2,0100 | -7,80 | |
| 1,1500 | -8,00 | |
| 11,900 | -9,85 | |
| 1,9520 | -12,07 |
Beitrag zu dieser Diskussion schreiben
Feedback
Antwort auf Beitrag Nr.: 48.083.671 von ernie070781 am 20.10.14 14:19:53Keine Sorge, die nächste Börsenschwäche wird wahrscheinlich schneller kommen, als uns allen lieb ist. Deshalb: immer ein bisschen Pulver trocken halten. :-)
Antwort auf Beitrag Nr.: 48.071.443 von 1435905 am 17.10.14 22:31:28
"eine Aktie, über die es sich immer lohnt, das ein oder andere Wörtchen zu verlieren."
kaufen - halten - Dividenden kassieren - vererben 
Das Problem ist das man hier oft sehr lange Geduld haben muss. Ich warte schon 2 Jahre um mal bei Schwäche ein bisschen nachzukaufen. Leider klappt das im Moment nicht.
Halte das auch eher für ein Qualitätsmerkmal, wenn wenig über die Aktie gesprochen wird...
Ich glaube, hier kann man nicht viel falsch machen, wenn man ein wenig aufpasst, dass man Colgate nicht immer nur zu Höchstkursen kauft.
Ich glaube, hier kann man nicht viel falsch machen, wenn man ein wenig aufpasst, dass man Colgate nicht immer nur zu Höchstkursen kauft.
Antwort auf Beitrag Nr.: 48.083.215 von ernie070781 am 20.10.14 13:36:43Erst wenn diese Aktien bei w:o unter "meistdiskutierte Werte" auftauchen, müssen wir vorsichtig sein 
Trading Spotlight
Bin auch Investiert. Hier passiert eben Monate lang nichts. Die Aktie ist natürlich auch sehr teuer. Ich denke mal deswegen guckt hier keiner groß nach und erwartet was vom Kurs.
Antwort auf Beitrag Nr.: 48.071.443 von 1435905 am 17.10.14 22:31:28
Das durchschnittliche w:o-Publikum interessiert sich eher für Mode-Aktien, mit denen man zocken kann. Solider Vermögensaufbau ist eher weniger gefragt.
Ich sage nur: Colgate, Novo Nordisk, Fresenius...
Zitat von 1435905: Ich habe irgendwie das Gefühl, dass in den w:o Foren bei Einzelwerten gar nichts mehr los ist...
Dabei ist doch auch und gerade Colgate eine Aktie, über die es sich immer lohnt, das ein oder andere Wörtchen zu verlieren.
Das durchschnittliche w:o-Publikum interessiert sich eher für Mode-Aktien, mit denen man zocken kann. Solider Vermögensaufbau ist eher weniger gefragt.
Ich sage nur: Colgate, Novo Nordisk, Fresenius...
bin dabei.ist ein anchor investment für uns.wird weiter aufgekauft
Ich habe irgendwie das Gefühl, dass in den w:o Foren bei Einzelwerten gar nichts mehr los ist...
Dabei ist doch auch und gerade Colgate eine Aktie, über die es sich immer lohnt, das ein oder andere Wörtchen zu verlieren.
Dabei ist doch auch und gerade Colgate eine Aktie, über die es sich immer lohnt, das ein oder andere Wörtchen zu verlieren.
Hier ein bisschen ausführlicher:
Colgate-Palmolive Q2 Profit Rises, Meets View; Affirms 2014 Outlook
NEW YORK CITY (dpa-AFX) - Consumer goods giant Colgate-Palmolive Co. (CL) on Thursday reported an 11 percent increase in profit for the second quarter from last year, as flat sales were more than offset by higher margins and fewer charges.
Adjusted earnings per share matched analysts' expectations, while quarterly revenues missed their estimates. Looking ahead, the company affirmed that it expects earnings per share growth with strong organic sales growth and gross margin expansion for full-year 2014.
The New York-based consumer goods major reported net income attributable to the company for the second quarter of $622 million or $0.67 per share, up from $561 million or $0.60 per share in the prior-year quarter.
The results for the latest quarter include $0.06 per share of after-tax charges resulting from the implementation of four-year Global Growth and Efficiency Program, and costs associated with the sale of land in Mexico. The year-ago quarter's results included after-tax charges of $0.10 per share.
Excluding items, adjusted net income for the latest quarter was $676 million or $0.73 per share, compared to $662 million or $0.70 per share in the year-ago quarter.
On average, 23 analysts polled by Thomson Reuters expected the company to report earnings of $0.73 per share for the quarter. Analysts' estimates typically exclude special items.
Worldwide net sales for the quarter edged up to $4.352 billion from $4.346 billion in the same quarter last year, but missed analysts' consensus estimate of $4.41 billion.
Global unit volume grew 2.5 percent, while pricing increased 1.5 percent and foreign exchange was negative 4 percent. Organic sales grew 4 percent, led by the emerging markets where organic sales grew 6.5 percent.
Total oral, personal and home care sales edged down to $3.792 billion from $3.797 billion in the prior-year quarter, while pet nutrition sales grew to $560 million from $549 million last year.
On a geographic basis, net sales declined 1.5 percent in Asia, while it increased 6 percent in Europe/South Pacific and 1 percent in North America. Latin America sales declined 4 percent and Africa/Eurasia sales decreased 1 percent.
Emerging markets sales in the quarter were down 2 percent, while sales grew 3 percent in developed markets.
Gross profit margin for the quarter rose 30 basis points from the year-ago period to 58.6 percent, while operating profit margin expanded 170 basis points to 22.5 percent.
In July, Colgate-Palmolive received notice of an adverse decision in a foreign court regarding a tax position taken in prior years.
Although the company plans to appeal this decision, it reassessed its tax position in light of the decision and expects to incur a one-time income tax charge of $68 million in the third quarter of fiscal 2014.
For fiscal 2014, Colgate-Palmolive affirmed that it expects another year of strong organic sales growth and gross margin expansion, with adjusted earnings per share projected to grow 4 to 5 percent on a dollar basis.
Street is currently looking for full-year 2014 earnings of $2.99 per share on annual revenues of $17.74 billion.
'Our 2012 Restructuring Program is on track and proceeding smoothly. We also continue to be sharply focused on our aggressive funding-the-growth programs and our strategic worldwide pricing initiatives,' Cook added.
CL closed Wednesday's trading at $66.11. In Thursday's pre-market activity, the stock is down $1.37 or 2.06 percent to $64.99.
Copyright RTT News/dpa-AFX
© 2014 AFX News
Colgate-Palmolive Q2 Profit Rises, Meets View; Affirms 2014 Outlook
NEW YORK CITY (dpa-AFX) - Consumer goods giant Colgate-Palmolive Co. (CL) on Thursday reported an 11 percent increase in profit for the second quarter from last year, as flat sales were more than offset by higher margins and fewer charges.
Adjusted earnings per share matched analysts' expectations, while quarterly revenues missed their estimates. Looking ahead, the company affirmed that it expects earnings per share growth with strong organic sales growth and gross margin expansion for full-year 2014.
The New York-based consumer goods major reported net income attributable to the company for the second quarter of $622 million or $0.67 per share, up from $561 million or $0.60 per share in the prior-year quarter.
The results for the latest quarter include $0.06 per share of after-tax charges resulting from the implementation of four-year Global Growth and Efficiency Program, and costs associated with the sale of land in Mexico. The year-ago quarter's results included after-tax charges of $0.10 per share.
Excluding items, adjusted net income for the latest quarter was $676 million or $0.73 per share, compared to $662 million or $0.70 per share in the year-ago quarter.
On average, 23 analysts polled by Thomson Reuters expected the company to report earnings of $0.73 per share for the quarter. Analysts' estimates typically exclude special items.
Worldwide net sales for the quarter edged up to $4.352 billion from $4.346 billion in the same quarter last year, but missed analysts' consensus estimate of $4.41 billion.
Global unit volume grew 2.5 percent, while pricing increased 1.5 percent and foreign exchange was negative 4 percent. Organic sales grew 4 percent, led by the emerging markets where organic sales grew 6.5 percent.
Total oral, personal and home care sales edged down to $3.792 billion from $3.797 billion in the prior-year quarter, while pet nutrition sales grew to $560 million from $549 million last year.
On a geographic basis, net sales declined 1.5 percent in Asia, while it increased 6 percent in Europe/South Pacific and 1 percent in North America. Latin America sales declined 4 percent and Africa/Eurasia sales decreased 1 percent.
Emerging markets sales in the quarter were down 2 percent, while sales grew 3 percent in developed markets.
Gross profit margin for the quarter rose 30 basis points from the year-ago period to 58.6 percent, while operating profit margin expanded 170 basis points to 22.5 percent.
In July, Colgate-Palmolive received notice of an adverse decision in a foreign court regarding a tax position taken in prior years.
Although the company plans to appeal this decision, it reassessed its tax position in light of the decision and expects to incur a one-time income tax charge of $68 million in the third quarter of fiscal 2014.
For fiscal 2014, Colgate-Palmolive affirmed that it expects another year of strong organic sales growth and gross margin expansion, with adjusted earnings per share projected to grow 4 to 5 percent on a dollar basis.
Street is currently looking for full-year 2014 earnings of $2.99 per share on annual revenues of $17.74 billion.
'Our 2012 Restructuring Program is on track and proceeding smoothly. We also continue to be sharply focused on our aggressive funding-the-growth programs and our strategic worldwide pricing initiatives,' Cook added.
CL closed Wednesday's trading at $66.11. In Thursday's pre-market activity, the stock is down $1.37 or 2.06 percent to $64.99.
Copyright RTT News/dpa-AFX
© 2014 AFX News
Durchsuchen
26.05.24 · Aktienwelt360 · Colgate-Palmolive |
26.04.24 · dpa-AFX · Chevron Corporation |
11.04.24 · Aktienwelt360 · Colgate-Palmolive |